Chronic obstructive pulmonary disease (COPD) is frequently complicated by sarcopenia, a debilitating condition characterized by the accelerated loss of skeletal muscle mass and functional capacity. Compared with their healthy counterparts, individuals with COPD have a higher prevalence of developing sarcopenia. This disproportionate burden is driven by distinct, disease-specific biological mechanisms. Notably, COPD induces a structural muscle fiber shift from fatigue-resistant oxidative fibers (Type I) to force-predominant glycolytic fibers (Type II). This metabolic shift is fundamentally compounded by decreased capillarization and prominent intramuscular fat infiltration, which collectively compromise oxidative capacity and accelerate functional decline. Previous studies suggest that targeted nutritional intervention is critical in managing this complex phenotype, yet standard dietary guidelines routinely fall short. This presentation summarises the clinical recommendations and discusses how the nutritional supplementation would help and support the management for people with COPD.